Radioembolization with 90Yttrium microspheres:: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies -: Part 2:: Special topics

被引:157
作者
Salem, Riad [1 ]
Thurston, Kenneth G. [1 ]
机构
[1] Robert H Lurie Comprehens Canc Ctr, Dept Radiol, Chicago, IL 60611 USA
关键词
D O I
10.1097/01.RVI.0000235779.88652.53
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Yttrium-90 microspheres are increasingly being used as a treatment modality for primary and secondary liver tumors. As these therapies continue to be accepted, it is natural that their application in more complex clinical scenarios will become more common. This article is meant to introduce these controversies and to generate interest and dialogue by the interventional oncology community. This discussion is based on more than 900 Y-90 radioembolization procedures performed over a 5-year period.
引用
收藏
页码:1425 / 1439
页数:15
相关论文
共 120 条
[61]  
LEWANDOWSKI R, 2006, SOC INT RAD ANN M MA
[62]   90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver:: Response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging [J].
Lewandowski, RJ ;
Thurston, KG ;
Goin, JE ;
Wong, CYO ;
Gates, VL ;
Van Buskirk, M ;
Geschwind, JFH ;
Salem, R .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2005, 16 (12) :1641-1651
[63]   HEPATIC ARTERIAL EMBOLIZATION IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA - A RANDOMIZED CONTROLLED TRIAL [J].
LIN, DY ;
LIAW, YF ;
LEE, TY ;
LAI, CM .
GASTROENTEROLOGY, 1988, 94 (02) :453-456
[64]  
LIN G, 1984, SURGERY, V96, P517
[65]   Angiographic considerations in patients undergoing liver-directed therapy [J].
Liu, DM ;
Salem, R ;
Bui, JT ;
Courtney, A ;
Barakat, O ;
Sergie, Z ;
Atassi, B ;
Barrett, K ;
Gowland, P ;
Oman, B ;
Lewandowski, RJ ;
Gates, VL ;
Thurston, KG ;
Wong, CYO .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2005, 16 (07) :911-935
[66]   Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival [J].
Llovet, JM ;
Bruix, J .
HEPATOLOGY, 2003, 37 (02) :429-442
[67]   Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial [J].
Llovet, JM ;
Real, MI ;
Montaña, X ;
Planas, R ;
Coll, S ;
Aponte, J ;
Ayuso, C ;
Sala, M ;
Muchart, J ;
Solà, R ;
Rodés, J ;
Bruix, J .
LANCET, 2002, 359 (9319) :1734-1739
[68]   Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma [J].
Lo, CM ;
Ngan, H ;
Tso, WK ;
Liu, CL ;
Lam, CM ;
Poon, RTP ;
Fan, ST ;
Wong, J .
HEPATOLOGY, 2002, 35 (05) :1164-1171
[69]   RANDOMIZED TRIAL OF TARGETED CHEMOTHERAPY WITH LIPIODOL AND 5-EPIDOXORUBICIN COMPARED WITH SYMPTOMATIC TREATMENT FOR HEPATOMA [J].
MADDEN, MV ;
KRIGE, JEJ ;
BAILEY, S ;
BENINGFIELD, SJ ;
GEDDES, C ;
WERNER, ID ;
TERBLANCHE, J .
GUT, 1993, 34 (11) :1598-1600
[70]   HEPATIC PARENCHYMAL CHANGES AFTER INTRAARTERIAL Y-90 THERAPY - CT FINDINGS [J].
MARN, CS ;
ANDREWS, JC ;
FRANCIS, IR ;
HOLLETT, MD ;
WALKER, SC ;
ENSMINGER, WD .
RADIOLOGY, 1993, 187 (01) :125-128